| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872723 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages |
Abstract
The combined use of zoledronic acid and radiotherapy shows enhanced in vitro cytotoxicity for two human prostate and myeloma cancer cell lines over that expected for a simple additive effect from each treatment alone. A clinical trial is under way to test this combination therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ece M.D., Roger M. M.D., Urs O. Ph.D.,